Cath 2010a.

Methods	Randomised, double blind placebo controlled trial
Participants	60 participants meeting DSM‐IV‐TR criteria for PD with or without agoraphobia
Interventions	All participants receive 12 ERP standard sessions, and in the first 6 sessions they receive study medication either directly pre or post session: Group 1, n = 20 receive DCS pre and placebo post session; Group 2, n=20 receive placebo pre and DCS post‐session; and Group 3, n = 20 receive placebo both pre‐ and post‐sessions
Outcomes	Panic disorder and agoraphobia: the Mobility Inventory
Notes	Study ID: Euctr‐021198‐35‐Nl, NTR2050 (Nederlands trial register: http://www.trialregister.nl/)